Closing the loop for patients with Parkinson disease: where are we?
Closing the loop for patients with Parkinson disease: where are we?
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Although levodopa remains the most efficacious symptomatic therapy for Parkinson disease (PD), management of levodopa treatment during the advanced stages of the disease is extremely challenging. This difficulty is a result of levodopa’s short half-life, a progressive narrowing of the therapeutic window, and major inter-patient and intra-patient va...
Alternative Titles
Full title
Closing the loop for patients with Parkinson disease: where are we?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2675607768
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2675607768
Other Identifiers
ISSN
1759-4758
E-ISSN
1759-4766
DOI
10.1038/s41582-022-00674-1
